Rydex Biotechnology Inv (RYOIX)

68.42 +0.15 (+0.22%) At close: 08:01PM EDT

• Previous close: 68.27
• YTD return: 0.80%
• Expense ratio (net): 1.64%
• Category: Health
• Last cap gain: 42.00
• Morningstar rating: ★★★★★
• Morningstar risk rating: Above average
• Net assets: 109.62M
• Beta (5Y monthly): 0.78
• Yield: 0.00%
• 5y average return: N/A
• Holdings turnover: 61.00%
• Last dividend: N/A
• Average for category: N/A
• Inception date: 01 Sept 2004